This page lists the SEC filings reported by Immunocore Holdings plc.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-03-11 | FMR LLC | Immunocore Holdings plc | 4,386,070 | 10.0% | EDGAR |
| SC 13D/A | 2024-03-07 | GENERAL ATLANTIC, L.P. | Immunocore Holdings plc | 1,747,849 | 3.5% | EDGAR |
| SC 13G/A | 2024-02-14 | RTW INVESTMENTS, LP | Immunocore Holdings plc | 6,096,387 | 12.3% | EDGAR |
| SC 13G/A | 2024-02-14 | Rock Springs Capital Management LP | Immunocore Holdings plc | 2,661,507 | 5.4% | EDGAR |
| SC 13G | 2024-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Immunocore Holdings plc | 2,944,574 | 6.0% | EDGAR |
| SC 13G | 2024-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Immunocore Holdings plc | 4,312,611 | 8.7% | EDGAR |
| SC 13G/A | 2024-02-06 | WELLINGTON MANAGEMENT GROUP LLP | Immunocore Holdings plc | 5,498,677 | 11.1% | EDGAR |
| SC 13D/A | 2024-02-01 | BAKER BROS. ADVISORS LP | Immunocore Holdings plc | 2,452,871 | 5.0% | EDGAR |
| SC 13D/A | 2023-09-18 | GENERAL ATLANTIC, L.P. | Immunocore Holdings plc | 2,606,684 | 5.3% | EDGAR |
| SC 13D/A | 2023-06-15 | GENERAL ATLANTIC, L.P. | Immunocore Holdings plc | 2,855,897 | 5.9% | EDGAR |
| SC 13G/A | 2023-02-14 | Rock Springs Capital Management LP | Immunocore Holdings plc | 3,321,066 | 7.3% | EDGAR |
| SC 13G | 2023-02-14 | RTW INVESTMENTS, LP | Immunocore Holdings plc | 5,559,322 | 12.3% | EDGAR |
| SC 13D/A | 2023-01-17 | GENERAL ATLANTIC, L.P. | Immunocore Holdings plc | 3,225,700 | 7.1% | EDGAR |
| SC 13D/A | 2023-01-04 | GENERAL ATLANTIC, L.P. | Immunocore Holdings plc | 3,840,669 | 8.5% | EDGAR |
| SC 13D/A | 2022-12-20 | GENERAL ATLANTIC, L.P. | Immunocore Holdings plc | 4,356,892 | 9.6% | EDGAR |
| SC 13G/A | 2022-09-07 | Malin Life Sciences Holdings Ltd | Immunocore Holdings plc | 2,109,425 | 4.6% | EDGAR |
| SC 13D | 2022-07-21 | GENERAL ATLANTIC, L.P. | Immunocore Holdings plc | 5,322,575 | 11.5% | EDGAR |
| SC 13D/A | 2022-07-20 | BAKER BROS. ADVISORS LP | Immunocore Holdings plc | 4,685,690 | 9.9% | EDGAR |
| SC 13G | 2022-03-17 | Cross Nicholas John | Immunocore Holdings plc | 2,369,610 | 5.4% | EDGAR |
| SC 13G | 2022-02-18 | Laing Ian Michael | Immunocore Holdings plc | 2,358,650 | 5.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.